Media stories about Sunshine Heart (NASDAQ:CHFS) have been trending somewhat positive recently, according to Accern Sentiment. Accern scores the sentiment of press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sunshine Heart earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.7433465397126 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Separately, ValuEngine upgraded Sunshine Heart from a “strong sell” rating to a “sell” rating in a research note on Tuesday, October 31st.
Shares of Sunshine Heart (NASDAQ CHFS) traded up $12.73 during trading hours on Thursday, hitting $16.50. The stock had a trading volume of 10,020,500 shares, compared to its average volume of 88,100. Sunshine Heart has a 1 year low of $3.60 and a 1 year high of $576.00.
COPYRIGHT VIOLATION WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect Sunshine Heart (CHFS) Share Price” was originally posted by Markets Daily and is the property of of Markets Daily. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://www.themarketsdaily.com/2017/11/16/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-sunshine-heart-chfs-share-price.html.
Sunshine Heart Company Profile
CHF Solutions, Inc, an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.
Receive News & Ratings for Sunshine Heart Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sunshine Heart Inc and related companies with MarketBeat.com's FREE daily email newsletter.